Subcutaneous Immunoglobulin Therapy In The Chronic Management Of Myasthenia Gravis.

Alfituri, Nadia Abdelsalam Omran (2017-02-21)

Technical Report

Subcutaneous immunoglobulin therapy has been recently researched and shown to be favorable and to have advantages over intravenous immunoglobulin therapy, in the chronic management of myasthenia gravis. This report aims to discuss the findings of research into this new long term therapy option for myasthenia gravis.

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States